Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abyan Pharmed is a prominent Iranian pharmaceutical company and a key subsidiary of the Golrang Pharmaceutical Group. The company specializes in the development, manufacturing, and distribution of high-quality finished dosage forms, with a primary strategic focus on Central Nervous System (CNS) disorders and cardiovascular health. Its commercial portfolio includes a wide range of generic medications for conditions such as Alzheimer's disease, schizophrenia, depression, and epilepsy. Abyan Pharmed operates state-of-the-art manufacturing facilities in the Eshtehard Industrial Town that adhere to international Good Manufacturing Practice (GMP) standards. By leveraging the extensive distribution network of the Golrang Industrial Group, the company ensures broad access to essential medicines across the Iranian market and the Middle East region. Their commitment to quality and innovation has established them as a leader in the local neuropsychiatry therapeutic segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abyan Pharmed.